You are currently viewing a new version of our website. To view the old version click .

Decoding Cancer Signals Using Liquid Biopsy

This special issue belongs to the section “Cancer Causes, Screening and Diagnosis“.

Special Issue Information

Dear Colleagues,

Liquid biopsy is revolutionizing oncology practice as a minimally invasive and easily repeatable way to detect cancer-associated changes in the genome, transcriptome, epigenome, and proteome. These advancements provide tools to understand cancer biology, inform clinical decisions and monitor treatment responses.

We welcome authors to contribute articles for this Special Issue that highlight the recent and upcoming advancements in the uses of liquid biopsies in oncology treatments and cancer care. Articles may address any single circulating analyte or multi-analyte approach using any biological fluid, such as plasma, serum, urine, and cerebrospinal fluid (CSF), among others. We will accept both original research papers outlining breakthrough discoveries and review papers outlining current developments in liquid biopsies.

Dr. Fatima Shadma
Dr. Fatemeh Vafaee
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer signals
  • liquid biopsy
  • minimally invasive
  • cancer biology
  • clinical decisions

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694